Rising Number of Surgical Procedures Propel Demand for Wound Care Management
The increasing prevalence of chronic diseases such as ulcerative colitis, cardiac arrest, cancer, and brain hemorrhage has led to an upsurge in the demand for surgical procedures. According to the Australian Institute of Health and Welfare (AIHW), in 2020–2021, cardiovascular disease was the reason for the hospitalization of 600,000 people in Australia, representing 5.1% of all hospitalizations in the country. 146,000 of these required coronary angiography procedures; out of these, 97,200 (67%) were performed in males and 48,900 (33%) in females. An article published by Eurostats in 2023 states that transluminal coronary angioplasty was one of the top 10 surgical procedures performed in European countries in 2021. On average, it was performed on 553 out of 100,000 and 390 per 100,000 inhabitants in Croatia and Germany, respectively.
The growing prevalence of cancer, one of the chronic conditions requiring the surgical removal of tumors, is becoming a global health burden. According to the statistics provided by the National Center for Health Statistics (NCHS), the US recorded 1,958,310 new cancer cases and cancer patients succumbed to death in 609,820 in 2023. Surgical procedures for burns and scalds, and plastic surgeries performed for beauty enhancement contribute to the growth of the advanced wound care market. According to the global survey outcomes published by the International Society of Aesthetic Plastic Surgery (ISAPS) in 2021, plastic surgeons performed over 12.8 million procedures in 2021, representing a 19.3% increase compared to the number from 2020. Procedures such as cardiac surgeries or plastic surgeries result in surgical wounds and scarring. Most of the surgical wounds heal without any complications. However, in some cases, contact with the environment may lead to wound infection after surgery. This can lead to delays in the wound-healing process. The dressing used during operations absorbs any fluid weeping from the surgical wound, aids in the best conditions for healing, and protects the affected area during the healing process. Foam dressing and hydrogel dressings, among others, have emerged as feasible options to speed up the healing process owing to their antibacterial properties.
Advanced Wound Care Dressing Market: Segmental Overview
The advanced wound care dressing market is segmented on the basis of type, application, and end user. Based on type, the market is segmented into foam dressing, alginate dressing, hydrogel dressing, hydrocolloid dressing, collagen dressing, film dressing, and others. The foam dressing segment is anticipated to register the fastest CAGR in the market during 2022–2030. Foam dressings are absorbent and non-linting. They come in different thicknesses and have a non-adherent layer that allows for gentle removal without causing trauma. Some foam dressings come with an adhesive border and a film coating to provide additional protection against bacteria. They create a moist environment and insulation for the wound. They are available as pads, sheets, and pillow (cavity) dressings. Foam dressings can be used as primary or secondary dressings for partial- and full-thickness wounds producing minimal, moderate, or heavy drainage. They can also be used as a primary dressing to provide absorption and insulation or as a secondary dressing for wounds with packing. Additionally, foam dressings can be used to absorb drainage around tubes. These unique characteristics make them the most suitable type of dressing for chronic wounds, allowing for fast and effective healing.
Based on application, the advanced wound care dressing market is segmented into heavy exudated wounds, burns and scalds, ulcers/bedsores/cavity wounds, post-operative surgery wounds and injuries, and others. In terms of end user, the market is segmented into hospitals and clinics, specialty centers, homecare settings, and others.
Advanced Wound Care Dressing Market: Competitive Landscape and Key Developments
Triage Meditech Pvt. Ltd; Convatec Group PLC; MedSupply Inc.; Smith and Nephew; HARTMANN USA, Inc.; Medtronic; Medical Monks; 3M; Mölnlycke Health Care AB; Coloplast Corp; and MEDCU are among the leading companies operating in the advanced wound care dressing market. These players emphasize on expanding and diversifying their market presence, and acquiring a novel customer base, thereby tapping business opportunities prevailing in the advanced wound care dressing market.
A few of the examples of recent new product launches in the advanced wound care dressing market are mentioned below.
- In April 2023, Convatec Group Plc. acquired the anti-infective nitric oxide technology platform of 30 Technology Limited. In addition to its use in advanced wound care, Convatec plans to explore the potential application of this innovative technology platform across all of its business categories. The technology has potential applications beyond wound care as it can aid in the prevention of urinary tract infections and other transformative uses. This addition of an innovative technology platform would help Convatec boost its advanced wound care portfolio.
- In January 2023, Convatec launched the ConvaFoam family of advanced foam dressings designed to address the needs of healthcare professionals and patients in the US. ConvaFoam can be used on different wound types at any stage of wound severity, and it is a simple dressing choice for wound management and skin protection.
- In August 2022, the Medical Solutions Division of 3M Health Care introduced a new and advanced version of 3M Veraflo Therapy, which is a negative pressure wound therapy with instillation. The updated version comes with a new 3M Veraflo Cleanse Choice Complete Dressing Kit, along with a software upgrade for the 3M V.A.C. Ulta Therapy Unit, which is available to customers at no additional cost. These new offerings help simplify the process of care delivery for clinicians using Veraflo Therapy, by accelerating and simplifying the dressing changes as well as making them less painful for their patients compared to previous Veraflo Therapy dressings.